Resveratrol analog 1 is the analog of resveratrol, compound 48. Resveratrol is a naturally occurring polyphenolic phytoalexin with antioxidant, anti~inflammatory, cardioprotective and anti-cancer properties.

Physicochemical Properties

Molecular Formula	C14H11FO2
Molecular Weight	230.234347581863
Exact Mass	230.074
CAS #	861446-16-4
PubChem CID	11413570
Appearance	White to off-white solid powder
LogP	3.6
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	2
Heavy Atom Count	17
Complexity	259
Defined Atom Stereocenter Count	0
SMILES	C(/C1C=C(O)C=C(F)C=1)=C\C1C=CC(O)=CC=1
InChi Key	HQRPEIZLSDDCOA-OWOJBTEDSA-N
InChi Code	InChI=1S/C14H11FO2/c15-12-7-11(8-14(17)9-12)2-1-10-3-5-13(16)6-4-10/h1-9,16-17H/b2-1+
Chemical Name	3-fluoro-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenol
Synonyms	861446-16-4; 3-fluoro-5-[(E)-2-(4-hydroxyphenyl)ethenyl]phenol; SCHEMBL3682513;
HS Tariff Code	2934.99.9001
Storage	Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Shipping Condition	Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity

Targets	Natural polyphenolic phytoalexin; anti-oxidant; anti-inflammatory; cardioprotective; anti-cancer
References	[1]. Liu, Jing, "Synthesis of Resveratrol and Its Analogs, Phase-Transfer Catalyzed Asymmetric Glycolate Aldol Reaction, and Total Synthesis of 8,9-Methylamido-Geldanamycin" (2007). All Theses and Dissertations. 1415.

Solubility Data

Solubility (In Vitro)

DMSO : ~100 mg/mL (~434.35 mM)

Solubility (In Vivo)

Solubility in Formulation 1: 5 mg/mL (21.72 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 5 mg/mL (21.72 mM) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), suspension solution; with ultrasonication. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C，1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 5 mg/mL (21.72 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.)

Preparing Stock Solutions		1 mg	5 mg	10 mg
	1 mM	4.3435 mL	21.7174 mL	43.4348 mL
	5 mM	0.8687 mL	4.3435 mL	8.6870 mL
	10 mM	0.4343 mL	2.1717 mL	4.3435 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.